Existing clinical practice guidelines for NAS are generally of low quality and lack specific recommendations regarding discharge planning, follow-up, child protection or long-term medical management. Review is needed to assist in guiding best clinical care for this vulnerable group of children and their families. (CP) is one of the most common severe physical disabilities in childhood. Children with CP show a broad spectrum of severity, and most participate in the mainstream school system. We described standardised Year 3 test results among children with CP.
Shore Hospital, the 3 Sydney Medical School Northern-The University of Sydney North Shore Hospital Northern Sydney Local Health District Background: Cerebral palsy (CP) is one of the most common severe physical disabilities in childhood. Children with CP show a broad spectrum of severity, and most participate in the mainstream school system. We described standardised Year 3 test results among children with CP.
Method: We identified children with CP in NSW hospital inpatient records using ICD-10-AM codes and classified their motor symptom topography and co-morbid chronic conditions. We analysed linked records of educational outcomes (NAPLAN) for third-grade children for 2008-2014 in NSW government schools, including the relationship with disabilities.
Results: There were 3954 individuals with CP of whom 3089 were NSW-born. Seven hundred and sixty-six children had a linked 3rd grade NAPLAN record. Half of these children were exempt from the reading task (vs 1% among children without CP) and 32% attained a Z score > −1. Twenty percent had special needs adjustments when completing tests. Results for numeracy were similar. Children with more severe topography of motor symptoms or with chronic conditions including epilepsy and impaired hearing were more likely to be exempt from NAPLAN testing, and achieved lower scores.
Conclusions: While children with CP participate in mainstream schooling, half are excluded from NAPLAN tests. Multiple aspects of CP-related disability limit participation and attainment. Background: The use of complementary and herbal medicines has been increasing in pregnant women worldwide, despite limited safety data in pregnancy. The aim of this study was to explore the recommendations and information sources healthcare professionals use to determine the safety of non-prescribed supplements during pregnancy.
COMPLEMENTARY AND HERBAL SUPPLEMENT USE IN PREGNANCY: RECOMMENDATIONS AND INFORMATION SOURCES OF MATERNITY HEALTHCARE PROFESSIONALS
Method: An electronic survey was distributed to doctors, midwives, pharmacists, dieticians, lactation consultants and physiotherapists caring for pregnant patients at an Australian maternity hospital.
Results:
Responses were received from 54 healthcare professionals. Forty of 54 (74.1%) were concerned about the safety of their patients' supplements, while 35 of 54 (64.8%) felt they had access to trustworthy safety information. Supplements most commonly recommended to patients as safe to use were ginger (40.7%), probiotics (29.6%) and raspberry leaf (22.2%). Participants specifically requested further safety information for raspberry leaf, evening primrose oil, fish oil, probiotics, ginger, vitamin C, valerian, turmeric, blue kohosh and colloidal silver. Written resources most frequently consulted included MIMS (61.1%) and 'Google Searches' (29.6%), and health professionals most referred to were pharmacists (74.1%), doctors (22.2%), and naturopaths or herbalists (3.7%).
Conclusions: While most maternity healthcare professionals expressed concern about the safety of patient's self-initiated complementary or herbal supplements in pregnancy, their recommendations and the quality of information sources varied. Further education and access to unbiased safety information is required to empower healthcare professionals to provide informed recommendations to pregnant patients. University of Auckland, Liggins Institute, the 2 University of Auckland, Department of Health Systems Background: Infants at risk of neonatal hypoglycaemia are often screened using cot-side glucometers, but non-enzymatic glucometers are inaccurate, potentially resulting in over-and under-treatment, and low values require laboratory confirmation. More accurate enzymatic glucometers are available but apparently higher ward costs discourage their use. Our objective was to compare the cost of screening for neonatal hypoglycaemia using point-of-care enzymatic and non-enzymatic glucometers.
COST ANALYSIS OF COT-SIDE SCREENING METHODS
Method: A decision tree model was constructed using incidence data from the Sugar Babies Study. Costs evaluated include consumables and staff time. Sensitivity analyses assessed the impact of varying staff time, staff costs, probability that low results are confirmed via laboratory testing, the false positive and false negative rates of non-enzymatic glucometers, and the blood glucose concentration threshold.
Results: In the primary analysis, screening using an enzymatic glucometer costs NZ$86.94 while using a non-enzymatic glucometer costs NZ$97.08 per infant. Sensitivity analyses show that an enzymatic glucometer is cost saving with wide variations in staff time and costs, with any level of false positive rate of nonenzymatic glucometers, or if the proportion of laboratory confirmation of low values is ? 78%. Non-enzymatic glucometers are less costly if their false negative rate is increased beyond 15%, but instances of hypoglycaemia will be missed. Reducing the blood glucose concentration threshold to 1.94 mmol/L reduced the incidence of hypoglycaemia, and the cost of screening using a non-enzymatic glucometer to NZ$47.71.
Conclusions: In view of their lower cost under most circumstances and greater accuracy, enzymatic glucometers should be routinely utilised for point-of-care screening for neonatal hypoglycaemia.
